JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY) ›› 2017, Vol. 31 ›› Issue (1): 95-99.doi: 10.6040/j.issn.1673-3770.0.2016.203

Previous Articles     Next Articles

Efficacy of recombinant human epidermal growth factor in prevention of radioactive oral mucosa inflammation and acute radiation dermatitis for nasopharyngeal carcinoma.

  

  1. Department of Radiation Oncology, Liuzhou Peoples Hospital, Liuzhou 545006, Guangxi, China
  • Received:2016-05-09 Online:2017-02-16 Published:2017-02-16

Abstract: Objective To observe the efficacy of recombinant human epidermal growth factor(rhEGF)in prevention of radioactive oral mucosa inflammation and acute radiation dermatitis of nasopharyngeal carcinoma(NPC). Methods A total of 50 NPC patients(5 stage Ⅱ, 32 stageⅢ and 13 stage Ⅳa)in the department of radiation oncology of our hospital hospitalized from January 2014 to December 2015 were randomly divided into the experimental group(n=26)and the control group(n=24).The two groups were treated with intensity modulated radiation therapy on the whole course, 6 weeks a radiotherapy cycle. The control group was given cisplatin single agent chemotherapy, and every 7 days for a cycle, 5 to 6 cycles. On the basis of the treatment of the control group, the experimental group was treated with combination of rhEGF(oral spray and neck skin smear gel)in the same period of the treatment. Short-term efficacy of the two groups was evaluated with complete remission, partial remission, stable disease and progression disease. The toxicity and side-effects were evaluated by the National Cancer Institute Common Toxicity Criteria(NCI-CTC). Results The short-term efficacy of the two groups was basically equivalent(P>0.05). No patients died in the two groups due to the toxic side effects, and the main toxicities in the two groups were gastrointestinal toxicity, myelosuppression and abnormal liver function. All patients had happened radioactive oral mucosa inflammation and acute radiation dermatitis of the neck which level was over grade Ⅰ. The incidence of radioactive oral mucosa inflammation and acute radiation dermatitis of the neck over grade Ⅱ level in the experimental group(42.31% and 11.54%)were significantly lower than those of the control group(70.83% and 41.67%)(P=0.042, 0.035). Conclusion The method of combination radiotherapy and chemotherapy with rhEGF in the treatment of NPC can effectively reduce the incidence of 山东大学耳鼻喉眼学报31卷1期 -于斌,等.重组人表皮生长因子预防鼻咽癌放射性口腔黏膜炎和急性放射性皮炎的疗效观察 \=-toxicity and side-effects of radioactive oral mucosa inflammation and acute radiation dermatitis of neck which caused by radiotherapy and chemotherapy.

Key words: Recombinanthuman epidermal growth factor, Radioactive oral mucosa inflammation, Nasopharyngeal carcinoma, Acute radiation dermatitis of the neck

CLC Number: 

  • R739.63
[1] Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016[J]. CA Cancer J Clin, 2016, 66(1):7-30.
[2] 司勇锋,陶仲强.鼻咽癌病因学和防治研究[J].中国耳鼻咽喉头颈外科,2010,17(3):163-165.
[3] Cao SM, Liu ZW, Jia WH, et al. Fluctuations of epstein-barr virus serological antibodies and risk for nasopharyngeal carcinoma: a prospective screening study with a 20-year follow-up[J]. PLoS One, 2011, 6(4):e19100.
[4] Cao SM, Simons MJ, Qian CN. The prevalence and prevention of nasopharyngeal carcinoma in China[J]. Chin J Cancer, 2011, 30(2):114-119.
[5] 黄启洪,李艳华.四会市1978-2007年鼻咽癌发病趋势分析[J].中国肿瘤,2011,20(8):571-572. HUANG Qihong, LI Yanhua. An Analysis of Trend for Nasopharyngeal Carcinoma Incidence from 1978 to 2007 in Sihui City, Guangdong Province[J]. Chin Cancer, 2011, 20(8):571-572.
[6] 黄祥,曲超,姜新,等.鼻咽癌的治疗进展[J].中国老年学杂志,2015,35(11):3159-3161.
[7] Guigay J. Advances in nasopharyngeal carcinoma[J]. Curr Opin Oncol, 2008, 20(3):264-269.
[8] 钟海林, 陈国谋, 林丹平,等.69例鼻咽癌常规放疗与调强放疗的不良反应比较[J].临床耳鼻咽喉头颈外科杂志,2013,27(9):462-464. ZHONG Hailin, CHEN Guomou, LIN Danping, et al. Comparison of side effects of intensity modulated radiotherapy and conventional radiotherapy in 69cases with nasopharyngeal carcinoma[J]. Clin Otolaryngol Head Neck Surgery, 2013, 27(9):462-464.
[9] 蒋靖, 夏立君.他克莫司软膏联合重组人表皮生长因子凝胶治疗面部激素依赖性皮炎39例[J].中国皮肤性病学杂志, 2012, 26(6):506-508. JIANG Jing, XIA Lijun. Thirty-nine cases of hormone-dependent facial dermatitis treated with tacrolimus ointment and recombinant human epidermal growth factor gel[J]. Chin J Dermatovenereol, 2012, 26(6):506-508.
[10] 中国鼻咽癌临床分期工作委员会.鼻咽癌'92分期修订工作报告[J].中华放射肿瘤学杂志,2009,18(1):2-5.
[11] Schwartz LH, Bogaerts J, Ford R, et al. Evaluation of lymph nodes with RECIST 1.1.[J]. Eur J Cancer, 2009, 45(2):261-267.
[12] 傅志超,程惠华,李东石,等.鼻咽癌强调放疗联合尼妥珠单抗加同期顺铂化疗的临床观察[J].中国肿瘤防治杂志, 2011,18(18):1475-1477.
[13] 张典刚, 黄莉, 耿晓涛, 等. 局部晚期鼻咽癌强调放疗远期疗效分析[J]. 新疆医科大学学报, 2015, 38(1):17-20, 25. ZHANG Diangang, HUANG Li, GENG Xiaotao, et al. Long-term results in locally advanced nasopharyngeal carcinoma treated by intensity-modulated radiotherapy[J]. J Xinjiang Med Univ, 2015, 38(1):17-20, 25.
[14] ICRU report 50: Prescribing, recording, and reporting photon beam therapy[S]. Bethesda, MD: International Commission on Radiation Units and Measurem ents, 1993.
[15] ICRU report 62: Prescribing, recording, and reporting photon beam therapy(supplement to ICRU Report 50)[S]. Bethesda, MD: International Commission on Radiation Units and Measurem ents, 1999.
[16] 王跃建,邓燕明,虞幼军,等.鼻咽癌诊断和治疗[M].北京:人民卫生出版社, 2013:440.
[17] Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group(RTOG)and the European Organization for Research and Treatment of Cancer(EORTC)[J]. Int J Radiat Oncol Biol Phys, 1995, 31(5):1341-1346.
[18] 杜立法,王俊杰.放疗杀伤肿瘤细胞机制的研究进展[J].癌症进展,2014,12(4):341-345.
[19] 戴如立,林广明,骆映峰,等.重组人表皮细胞生长因子治疗急性放射性皮肤溃疡的临床观察[J].中国现代药物应用,2010,4(16):59-60.
[20] 刘尚贤,张春. 重组人表皮细胞生长因子在鼻咽癌放疗中预防放射性口咽炎疗效观察[J].中国医药科学,2014,4(20):168-169,172.
[21] 龚倩,谌赟,符一岚,等. 重组人表皮细胞生长因子联合氨磷汀治疗鼻咽癌患者放射性口腔黏膜炎的临床观察[J].中国药房,2015,26(14):1971-1973.
[22] Miyazaki M, Mars WM, Runge D, et al. Phenobarbital suppresses growth and accelerates restoration of differentiation markers of primary culture rat hepatocytes in the chemically defined hepatocyte growth medium containing hepatocyte growth factor and epidermal growth factor[J]. Exp Cell Resh, 1998, 241(2):445-457.
[23] Hong JP, Lee SW, Song SY, et al. Recombinant human epidermal growth factor treatment of radiation-induced severe oral mucositis in patients with head and neck malignancies[J]. Eur J Cancer Care(Engl), 2009, 18(6):636-641.
[24] Hong JP, Jung HD, Kim YW. Recombinant human epidermal growth factor(EGF)to enhance healing for diabetic foot ulcers[J]. Ann Plast Surg, 2006, 56(4):394-398; discussion 399-400.
[25] 吴宏,李燕,陈洁.重组人表皮生长因子凝胶与硝酸银软膏联合治疗放射性皮肤损伤[J].现代中西医结合杂志,2011,21(15):1678-1679.
[26] 郭杏,谭美云,郭力,等.重组人表皮细胞生长因子对供皮区创面的修复[J].中国组织工程研究,2010,14(5):862-865.
[1] ZHANG Caixia, LIU Yangyun, JIANG Wen, LIU Gengxun, CAO Hang, CHEN Qiong, ZHANG Jishuai. Investigation of chemosensitization induced by nitric oxide on nasopharyngeal carcinoma CNE-2 cells. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(5): 72-78.
[2] ZHOU Yibo, GONG Xiaorong, YU Feng. Effects of miR-150 targeted to Nanog on proliferation and invasion of nasopharyngeal carcinoma side population cells. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(5): 79-84.
[3] DU Zhihong. Application of oro-nasal combination approach under electronic nasopharyngoscope in the nasopharyngeal biopsy. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(4): 117-118.
[4] . Effects of concurrent chemotherapy and radiotherapy on the quality of life in children and adolescents with nasopharyngeal carcinoma. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(2): 55-58.
[5] . Construction of c-Met target chimeric antigen receptor T cells and evaluation the role on nasopharyngeal carcinoma cells. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2017, 31(2): 49-54.
[6] WANG Yaning, GENG Bo, LI Baiyan, CUI Chaoyang, WANG Qirong. The treatment experience on osteoradionecrosis of skull base with nasopharyngeal carcinoma after radiotherapy. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(6): 42-45.
[7] LIU Ye, SUN Dianshui, YIN Jinjun, XIA Ming, XU Ying, SUN Jianhua. Vestibular function damage mechanisms in nasopharyngeal carcinoma patients after intensity-modulated radiotherapy. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(6): 14-17.
[8] WANG Junying, LI Xiaofeng. Effect of deproteinized extract of calf blood gel eye on the injury of corneal endothelial cells after nasopharyngeal carcinoma radiotherapy. [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2016, 30(1): 76-79.
[9] ZHAO Yanlian, LU Yongtian, YANG Jihong, ZHANG Juan, MIAO Fangfang, LI Jieping. Relationship between the expression of EGFL7 in nasopharyngeal carcinoma and the invasion and metastasis of tumor [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2015, 29(6): 31-35.
[10] CHE Juan, ZHAO Hongchun, LI Jinling, WANG Yanfei. The relationship between D-Dimer and nasopharyngeal carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2015, 29(5): 47-49.
[11] SHI Da-zhi1, LI Jian-ming2, LUO Zhi-qiang1, LUO Qin1, JING Qian-cheng1. Clinical analysis of nasopharyngeal carcinoma in pregnancy [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2014, 28(3): 28-30.
[12] ZHANG Xiao-peng1, BIAN Feng2, WANG Li-xin2. Expressions and relativity of COX-2 and EGFR in nasopharyngeal carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2014, 28(3): 23-27.
[13] ZHANG Zhong-hua1, WANG Xue-hai2, CAI Xiao-lan3. Expression and significance of p-PTEN, p-Akt and p-FoxO1 in nasopharyngeal carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2014, 28(2): 55-57.
[14] YANG Jian-ming. Relationship between radioactive otitis media and changes in cross section area of tensor veli palatine (TVP) muscle after radiotherapy in patients with nasopharyngeal carcinoma [J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2014, 28(1): 31-33.
[15] XU Yuan-yuan, ZENG Quan, HONG Su-ling, HU Guo-hua. Comparison of neoadjuvant chemotherapy followed by concurrent chemoradiotherapy versus concurrent  chemoradiotherapy alone in locoregionally advanced nasopharyngeal carcinoma: A meta analysis. [J]. J Otolaryngol Ophthalmol Shandong Univ, 2013, 27(5): 8-14.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] ZHAO Li-min, NI Kun, WU Jia-li, CHEN Shu-mei, LI Xiao-yan. Etiology and treatment of inspiratory laryngeal stridor in infants[J]. J Otolaryngol Ophthalmol Shandong Univ, 2013, 27(2): 49 -51 .
[2] SHI Chun-sheng1, ZHANG Qing-quan2, WANG Qiang2, SUN Yan2, GE Chang-yi1. Application of flaps in the reconstruction of soft palate defects[J]. J Otolaryngol Ophthalmol Shandong Univ, 2013, 27(2): 86 -88 .
[3] ZHANG Ling1, SUN Chuan-yi1, XU An-ting2. 1 case of petrous apex cholesteatoma deafness patients[J]. J Otolaryngol Ophthalmol Shandong Univ, 2013, 27(2): 93 -94 .
[4] . [J]. J Otolaryngol Ophthalmol Shandong Univ, 2013, 27(4): 1 -3 .
[5] LUO Hui-xiu, FAN Chun-tao, DENG Yan-hua. Therapeutic effects of adenoidectomy and tonsillectomy in children with obstructive sleep apnea hypopnea syndrome[J]. J Otolaryngol Ophthalmol Shandong Univ, 2013, 27(4): 17 -20 .
[6] HAO Ying-juan1, YANG Qing-song2, ZHOU Yue-hua2, YI Sheng-ping1, ZHAI Chang-bin2. Characteristics of thin corneal flaps created with Wavelight FS200 femtosecond laser[J]. J Otolaryngol Ophthalmol Shandong Univ, 2013, 27(4): 26 -31 .
[7] WEN Hua-ming1, LI Hai-xiang2. Application of trianglar function method to calculate intra ocular lens power after myopic laser in situ keratomileusis[J]. J Otolaryngol Ophthalmol Shandong Univ, 2013, 27(5): 74 -76 .
[8] ZHU Jian, HE Qing-qing, ZHENG Lu-ming, FAN Zi-yi, ZHAO Guo-wei, HOU Lei, SHI Hou-bin. Clinical analysis for 57 re-operational cases of differentiated thyroid cancer[J]. J Otolaryngol Ophthalmol Shandong Univ, 2013, 27(6): 9 -12 .
[9] LI Shao-hua, SUN Yi-fan, LU Biao-qing. Application of double vascularized soft tissue flap in open radical mastoidectomy[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2014, 28(1): 6 -7 .
[10] WEI Xi-jian1, YIN Rui-lan2, GUO Xing3. Expression of a proliferation-inducing ligand in laryngeal squamous cell carcinoma[J]. JOURNAL OF SHANDONG UNIVERSITY (OTOLARYNGOLOGY AND OPHTHALMOLOGY), 2014, 28(1): 14 -16 .